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Purpose: The efficacy of carotid endarterectomy (CEA) for prevention of stroke has been demonstrated in randomized
trials; however, the optimal approach in patients excluded from these trials or who have other significant comorbid
conditions remains controversial, particularly with the advent of percutaneous interventions. We examined the influence
of putative risk factors on outcome of CEA in a single-center experience.
Methods: A retrospective analysis of 1370 consecutive CEA performed from 1990 to 1999 was undertaken. Preoperative
risk factors examined included age older than 80 years, congestive heart failure, chronic obstructive pulmonary disease,
renal failure (serum creatinine concentration > 2.0 mg/dL), contralateral carotid artery occlusion, recurrent ipsilateral
carotid artery stenosis, ipsilateral hemispheric symptoms within 6 weeks, and recent coronary bypass grafting (CABG).
The Fisher exact test was used to identify baseline variables associated with perioperative (30 days) risk for stroke or
death. Multivariate analysis with Poisson regression was used to study the effect of all univariate criteria in combination.
Results: In the overall cohort, there were 32 adverse events (2.3%), including 11 deaths (0.8%), 6 disabling strokes (0.4%),
and 10 nondisabling strokes (0.7%). There was no significant difference in incidence of perioperative stroke or death
between patients with one or more risk factors (n  689) and those with no risk factors (low risk, n  681). Thirty-day
mortality was significantly greater in patients with two or more risk factors compared with patients with no risk factors
(2.8% vs 0.3%; P  .04), but no significant difference was noted in perioperative stroke rate (2.3% vs 1.0%). Univariate
analysis demonstrated that contralateral carotid occlusion (n 75) was the only significant predictor of adverse outcome
(5 events, 6.7%) among the variables tested; this was confirmed with multivariate analysis (relative risk, 4.3; 95%
confidence interval, 1.2-12.3; P  .01). Five-year survival for patients with two or more risk factors was notably
diminished compared with that for patients with no risk factors (38.7% 5.9% vs 75.0% 2.6%; P < .001). Contralateral
occlusion was also associated with reduced 5-year survival (38  11% vs 67  2%; P < .004).
Conclusion: CEA can be safely performed in patients deemed at high risk, including those aged 80 years or older and
others with significant comorbid conditions, with combined stroke and mortality rates comparable to those found in
randomized trials, ie, the Asymptomatic Carotid Atherosclerosis Study and the North American Symptomatic Carotid
Endarterectomy Trial. Contralateral occlusion may be a predictor for moderately increased perioperative risk and for
reduced long-term survival. Caution may be warranted in asymptomatic patients with multiple risk factors, in whom
presumed long-term benefit of CEA may be compromised by markedly reduced 5-year survival. (J Vasc Surg 2003;37:
1191-9.)
Carotid endarterectomy (CEA) is a well-established
treatment for reduction of stroke in patients with and
without symptoms.1,2 Although both the North American
Symptomatic Carotid Endarterectomy Trial (NASCET)
and Asymptomatic Carotid Atherosclerosis Trial (ACAS)
demonstrated significant risk reduction associated with sur-
gery versus medical therapy, the relative risk–benefit ratio
in some patient subgroups and for patients excluded from
these trials because of age or comorbid condition, remains
in question. Inasmuch as both studies demonstrated a
prolonged protective effect of CEA on ipsilateral stroke, the
critical determinants of benefit for an individual patient are
perioperative event rate and expected long-term survival. In
the wake of NASCET and ACAS, multiple studies have
attempted to further define subgroups of patients who may
be at increased perioperative risk, on the basis of trial
exclusion criteria and other clinical variables.3-7
An alternative intervention for treatment of carotid
artery occlusive disease, percutaneous carotid angioplasty
and stenting, has been under investigation in the United
States since 1994.8 Although devices and technology for
this procedure are evolving, contemporary reports from
experienced interventionalists suggest that early results are
approaching those with CEA, and a large-scale randomized
trial has been initiated.9 Advocates of carotid stenting
propose that this technique may be safer than CEA in
patients deemed at high risk for open surgery or otherwise
excluded from NASCET and ACAS.
The purpose of this study was to examine the influence
of defined preoperative risk factors, including randomized
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trial exclusion criteria, on the outcome of CEA in a single
tertiary care hospital. We hoped to better stratify the ex-
pected benefits of open CEA in our own institutional
experience and to potentially define a subset of high-risk
patients in whom carotid stenting might be considered as a
therapeutic alternative.
PATIENTS AND METHODS
The computerized vascular registry at Brigham and
Women’s Hospital was used to retrospectively identify
1370 consecutive CEA procedures performed in 1184
patients from January 1, 1990, to December 31, 1999, by
five surgeons. Standard demographic data and cardiovascu-
lar comorbid conditions were determined prospectively for
all patients. Review of recent literature identified several
risk factors that have been suggested as predictors of ad-
verse outcome associated with CEA, including age older
than 80 years, congestive heart failure (CHF), chronic
obstructive pulmonary disease (COPD), chronic renal fail-
ure (serum creatinine concentration  2.0 mg/dL), con-
tralateral carotid artery occlusion, recurrent ipsilateral ca-
rotid artery stenosis, recent ipsilateral hemispheric transient
ischemic attack (TIA) or stroke within 6 weeks, or coronary
artery bypass grafting (CABG) within 6 months.1-5,10,11
Patients were stratified according to presence of none, one,
or two or more of these risk factors.
Hospital charts, office correspondence, computerized
records, and the Social Security Death Index were re-
viewed. In all patients with suspected adverse events, results
of imaging studies, including computed tomography (CT),
magnetic resonance imaging (MRI), contrast material–
enhanced angiography, and duplex ultrasound (US) scan-
ning, were also reviewed. All consecutive patients undergo-
ing isolated CEA during the study interval were included.
Data for patients who had undergone a combined proce-
dure, ie, CABG, were separately analyzed for comparison.
CEA was performed in most cases on the basis of
identification of internal carotid artery stenosis at Duplex
US scanning performed in the noninvasive vascular labora-
tory. Selective carotid angiography or magnetic resonance
arteriography was used when additional anatomic informa-
tion was required. Preoperative cardiac risk assessment was
routine in all patients. Type of anesthetic used, ie, regional
or general, was at the discretion of the surgeon; most
procedures were performed with the patient under general
anesthesia. Selective shunting was used on the basis of
neurologic changes with regional anesthesia or electroen-
cephalographic changes with general anesthesia. Synthetic
patches were routinely used, with rare use of greater saphe-
nous vein, as deemed necessary by the operating surgeon.
Heparin reversal with protamine sulfate was infrequently
used. Continuous-wave Doppler ultrasound scanning with
the handheld instrument and completion arteriography
were routinely performed during the first 5 to 6 years of the
study. Subsequent introduction of intraoperative duplex
US scanning replaced arteriography in the last 4 years.
Perioperative care typically included observation in the
recovery room for 4 hours, followed by transfer to a regular
surgical nursing unit with selective cardiac monitoring. The
surgical intensive care unit was not routinely used. Serial
electrocardiography and enzyme assays were performed to
assess cardiac morbidity in the postoperative period. Aspirin
(325 mg) was administered routinely preoperatively and
long-term postoperatively. Postoperative clinical follow-up
visits occurred within thirty days of operation and included
selective duplex US scanning.
Primary end points included perioperative stroke,
death, and combined stroke-death rate, defined by the
reporting standards of an ad hoc committee of The Society
for Vascular Surgery and the North American chapter of the
International Society for Cardiovascular Surgery on Cere-
brovascular Reporting.12 Stroke was defined as persistence
of a clinical neurologic deficit beyond 24 hours. Stroke as
an outcome event was classified as disabling or nondis-
abling at 30 days postoperatively. Disabling stroke was
defined as a new and persistent neurologic defect that
significantly impaired outcome, and nondisabling stroke
was characterized as any new neurologic symptom or sign
persisting for more than 24 hours but producing no signif-
icant functional disability.
Univariate tests were used initially to investigate the
influence of patient characteristics on outcome of stroke or
death during or after surgery. The Student t test was used
for age and duration of follow-up. The Fisher exact test was
used for gender, history of CABG within 6 months of
carotid surgery, history of chronic renal failure, history of
CHF, history of COPD, contralateral carotid artery occlu-
sion, recurrent carotid artery stenosis, and preoperative
symptoms of hemispheric TIA or stroke within 6 weeks of
surgery. Patient categorical variables were analyzed with a
X2 test. Multivariate analysis with Poisson regression was
subsequently used to determine the effect of all variables
together, then only those variables determined statistically
significant on the basis of results of univariate and Poisson
analyses. Patients were declared lost to follow-up (23%)
when no patient contact occurred within 18 months. Cu-
mulative patient survival was calculated with the life table
method, and survival data were compared with the log-rank
test. P  .05 was considered statistically significant.
RESULTS
Study cohort and prevalence of risk factors. During
the study 1184 patients underwent 1370 CEA; 689 pa-
tients (50%) had at least one risk factor. Symptomatic
disease was the indication for CEA in 626 proceduress
(46%), and the remaining 744 procedures (54%) were
performed in patients without symptoms. Seventy-four
percent of CEA in the cohort with one or more risk factors
were performed in patients with a single risk factor, and the
remaining 26% (176 CEA) were performed in patients with
two or more risk factors. Baseline characteristics of the
groups with either one or more risk factors or no risk factors
are outlined in Table I. No significant difference was appre-
ciated between these groups in terms of gender, diabetes,
or smoking status; however, a greater number of patients
with one or more risk factors were operated on because of
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symptomatic carotid artery disease (P  .001). Prevalence
of individual risk factors in symptomatic and asymptomatic
cohorts stratified to one risk factor or two or more risk
factors is shown in Table II. The most common risk factor
in the symptomatic cohort was an ipsilateral hemispheric
event within 6 weeks of surgery; in the asymptomatic
cohort age greater than 80 years was the predominant risk
factor. CEA in patients without symptoms was most com-
monly performed in those at low risk (no risk factors, n 
529; 71%), compared with patients with one risk factor (n
 188; 25%) or two or more risk factors (n  27; 4%). In
comparison, CEA in patients with symptoms was most
commonly performed in patients with one risk factor (n 
330; 53%), compared with patients with no risk factors (n
152; 24%) or two or more risk factors (n  144; 23%).
Perioperative mortality and morbidity. In the over-
all study cohort, there were 32 adverse events (2.3%),
including 11 deaths (0.8%), 6 disabling strokes (0.4%), and
10 nondisabling strokes (0.7%). Five patients (0.4%) had
fatal strokes, counted as both types of adverse event. Of the
11 deaths, 9 occurred in patients with at least one preop-
erative risk factor (one risk factor in 4 patients, two or more
risk factors in 5 patients). Thirteen patients (0.9%) had a
myocardial infarction postoperatively, 7 (1.0%) in the
group with one or more risk factors and 6 (0.9%) in the
group with no risk factors (difference not significant). All
groups were comparable with regard to hematoma forma-
tion (2.3%), repeat operation because of bleeding (0.7%),
and wound infection (0.1%).
Overall, 21 strokes (1.5%) occurred in the postopera-
tive period, 5 of which resulted in death within 30 days.
Seven strokes were in patients with no risk factors, and 14
were in patients with one or more risk factors. Of the 16
perioperative strokes in surviving patients, 6 were disabling
and 10 were nondisabling. All 6 disabling strokes were
ipsilateral to the CEA. Four disabling strokes occurred in
patients with no risk factors, and 2 were in patients with one
or more risk factors. Eight of 10 patients with nondisabling
stroke had at least one risk factor. Most (9 of 10) nondis-
abling strokes were due to minor embolization not identi-
fiable on CT scans or MR images, and one was related to
reperfusion syndrome.
Thirty-day perioperative stroke, death, and combined
stroke-death rate for each patient group are depicted in Fig
1, A. No difference in stroke rate was appreciated between
the group with no risk factors and the group with one or
Table I. Characteristics of patients undergoing CEA
Characteristics
Overall Low risk High risk
n % (0 RF) (1 RF)
N (patient/procedure) 1184/1370 596/681 588/689
Male gender 781 57 391 57 390 56
Diabetes 304 22 150 22 154 22
Tobacco 342 25 170 25 119 23
Hypertension 877 64 446 66 431 63
Asymptomatic disease 744 54 529 78 215 31*
Prior ipsilateral stroke or
TIA†
284 21 82 12 202 29*
Symptomatic disease 626 46 152 22 474 69*
Amaurosis 211 15 152 22 59 9*
TIA 311 23 —— 311 45
Stroke 104 8 —— 104 15
CEA, Carotid endarterectomy; RF, risk factor; TIA, transient ischemic attack.
*P 0.001 when comparing high risk and low risk groups; all other values not significant.
†More than 6 weeks before CEA.
Table II. Risk factors in patients at high risk undergoing isolated CEA
Disease
CABG
(in 6 mo) CHF COPD
Creatinine
2.0 mg/dL
Contralateral
occlusion Repeat CEA Age 80 y
Hemispheric
stroke/TIA*
n % n % n % n % n % n % n % n %
Symptomatic
1 RF 6 2 0 18 5 1 1 3 1 9 3 15 4 278 84
2 RF 14 10 8 6 42 29 19 13 21 15 12 8 62 43 32 22
Asymptomatic
1 RF 24 13 7 4 28 15 7 4 43 22 13 7 66 35 ——
2 RF 8 30 8 30 10 37 5 18 8 30 2 7 14 52 ——
Percent represents percentage of procedure.
CEA, Carotid endarterectomy; CABG, coronary artery bypass grafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; RF, risk
factor; TIA, transient ischemic attack.
*Ipsilateral hemispheric ischemic event within 6 weeks of CEA.
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more risk factors (1.0% vs 2.0%, respectively; P  .13).
Subgroup analysis revealed no difference in stroke rate for
patients with one risk factor versus those with two or more
risk factors (1.9% vs 2.3%; P  .79). Thirty-day mortality
rate was significantly higher in patients with one or more
risk factors (9 patients, 1.3%) compared with those with no
risk factors (2 patients, 0.3%; P  .04). Among patients
with at least one risk factor, 30-day mortality was higher in
those with two or more risk factors (5 patients, 2.8%)
compared with those with only a single risk factor (4
patients, 0.8%; P  .04).
Thirty-day perioperative stroke, death, and combined
stroke-death rates for asymptomatic and symptomatic pa-
tient subgroups are depicted in Fig 1B and C respectively.
Overall event rates in the symptomatic cohort (0.6% death,
1.6% stroke) compared with the asymptomatic cohort
(1.3% death, 1.5% stroke) were not different. Among
asymptomatic patients, perioperative mortality was higher
in those with two or more risk factors (3 deaths in 27
patients, 11%) compared with those with one risk factor
(1.1%; P  .02) or no risk factors (0.6%; P  .001).
Perioperative stroke rate was not statistically different be-
tween risk factor cohorts in patients without symptoms,
although the combined stroke-death end point was signif-
icantly higher (7.8%) in patients with contralateral occlu-
sion compared with those with no risk factors (1.5%; P 
.001). In contrast, there were no significant differences in
adverse events between risk factor cohorts in patients with
symptoms, in which the absolute number of events re-
mained small and the denominator was larger than in the
corresponding asymptomatic groups.
Influence of individual risk factors. One hundred
sixty CEA were performed in patients 80 years of age or
older at operation, of which 83 (52%) were performed to
treat asymptomatic disease and 77 (48%) were performed
to treat symptomatic disease. The combined adverse event
rate in octogenarians was 3.7% (2.5% death, 1.2% stroke),
with all adverse events occurring in patients without symp-
toms (difference not significant when compared with the
group with symptoms).
Univariate analysis of the eight putative high-risk crite-
ria found only contralateral occlusion to be a significant
predictor of poor outcome (P  .01), with CHF having a
marginal association (P .06). Neither age nor gender was
found to be a significant predictor of outcome. Poisson
regression modeling was used to determine which of the
individually important variables, considered in combina-
Fig 1. Adverse perioperative events after isolated carotid artery endarterectomy (CEA), grouped by risk factor cohorts.
A, Thirty-day stroke, death, and combined stroke-death rates in the total population. Numbers in parentheses represent
number of CEA performed. P  .003 for stroke rate for contralateral occlusion vs no risk factors (0 RF); P not
significant for all other stroke rate comparisons; P  .050 for death rate for two risk factors (2 RF) vs no risk factors,
one risk factor (1 RF), and combined stroke-death rate for contralateral occlusion vs no risk factor or one risk factor.
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tion, identified patients at high risk. In this analysis only
contralateral occlusion (relative risk, 4.3; 95% confidence
interval, 1.2-12.3; P  .01) was significantly associated
with poor outcome after CEA (Table III). Among 75
patients with contralateral carotid occlusion, 5 (6.7%) had
adverse perioperative outcome (1 death, 1 disabling stroke,
3 nondisabling strokes). When the analysis was performed
separately for asymptomatic and symptomatic cohorts,
CHF (P  .03) and contralateral occlusion (P  .06)
remained marginally associated with events in the asymp-
tomatic group, whereas renal failure (P  .09) and con-
tralateral occlusion (P  .1) approached significance for in
the symptomatic group. Given the small number of events,
ability to determine the influence of individual factors was
reduced by classifying the overall population according to
presence of symptoms.
Long-term survival and artery patency. Survival
rates at 2 and 5 years after CEA are summarized in Table
IV. Overall 5-year cumulative survival for patients under-
going CEA was 67% 2.0%. Patients with two or more risk
factors had a distinctly lower 5-year survival rate (38.7% 
5.9%) compared with patients with no and one risk factor
(P  .001 for both comparisons), as shown in Fig 2.
Patients with contralateral carotid artery occlusion had
significantly diminished survival at both 2 years (P .046)
and 5 years (P  .004) years, compared with patients
without contralateral carotid occlusion, regardless of
whether they did or did not have symptoms. It is notable
that diminished survival associated with presence of two or
more risk factors or contralateral occlusion was equally
evident in both symptomatic and asymptomatic groups.
Noninvasive follow-up with duplex US scanning of the
carotid artery operated on (35% lost to US follow-up)
revealed a 5-year patency rate greater than 96%.
Combined CEA/CABG. To be completely inclusive
of all patients undergoing CEA at our institution during
the study, data for 144 patients who had undergone com-
bined CEA-CABG were separately analyzed. In compari-
son with patients undergoing isolated CEA with two or
more risk factors, the CEA-CABG group was composed of
significantly younger (mean age, 69 years), nondiabetic
male smokers, who were less likely to have COPD or renal
insufficiency and more often had no symptoms (74%) of
carotid disease (P  .008 for all comparisons between
CEA-CABG and isolated CEA groups with two or more
risk factors). A significantly higher number of perioperative
strokes (n  12, 8.2%) occurred in the CEA-CABG group
compared with patients undergoing isolated CEA with no,
one, or two or more risk factors (P  .01 for all compari-
sons). Three of 12 perioperative strokes in the CEA-CABG
cohort were ipsilateral to the endarterectomy side, 7 were
contralateral, and 2 were caused by diffuse bilateral embolic
Fig 1. B, Thirty-day stroke, death, and combined stroke-death rates in patients with asymptomatic disease. Numbers
in parentheses represent number of CEA performed. P not significant for all stroke rate comparisons; P .05 for death
rate for two risk factors and contralateral occlusion vs no risk factors.
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shower. Thirty-day operative mortality of 4.1% (6 patients)
for the combined procedure was comparable to that in the
group with two or more risk factors who underwent only
CEA, but was higher than that observed in the groups with
no or one risk factor (P  .001 for both comparisons).
DISCUSSION
CEA is an effective and durable procedure for stroke
prevention, according to carefully constructed clinical trials
involving well-defined patient populations. The conclu-
sions derived from these studies have been applied to a wide
variety of patients in clinical practice. Some advocates of a
percutaneous solution to carotid occlusive disease have
recommended carotid angioplasty and stenting for patients
excluded from randomized trials and presumed to be at
increased risk for open CEA. We undertook this retrospec-
tive study to attempt to define a subgroup of patients at
increased risk for adverse outcomes after CEA and to test
the influence of criteria proposed by others on these out-
comes.
Our results confirm those of randomized trials and
numerous other single-center reports in which the safety of
CEA in most patients was well demonstrated. Of the de-
fined preoperative variables examined in this study, only
one, contralateral carotid artery occlusion, was predictive of
adverse perioperative events after CEA. Specifically, age
greater than 80 years, gender, recent ipsilateral hemispheric
event, repeat operative carotid surgery, recent CABG,
CHF, and chronic renal failure were not individually asso-
ciated with a significant effect on perioperative mortality or
stroke in our series. A stepwise increase in perioperative
mortality, from 0.3% (no risk factors) to 2.8% (more than
two risk factors), was noted with presence of multiple risk
factors. However, the combined stroke-death rate in the
groups with more than two risk factors (5.1%) and, more
particularly, in patients with two or more risk factors and
symptomatic disease (2.8%) was still well within the range
of the NASCET findings (6.5%). A smaller denominator of
patients (n  27) in the asymptomatic cohort with two or
more risk factors implies that the apparent increase in
perioperative mortality (11%) should be interpreted with
caution. Nevertheless, the wisdom of CEA in patients with
asymptomatic disease with multiple risk factors is chal-
lenged by these observations.
A particularly striking and important finding was the
low 5-year cumulative survival rate of 39% in patients with
two or more risk factors (median 18 months) compared
with 65% in patients with one risk factor (P  .001) and
75% in low-risk (no risk factors) patient groups (P  .001)
at 5 years. Contralateral occlusion was also associated with
similarly diminished 5-year survival, and the influence of
these factors on survival was not related to the symptomatic
Fig 1. C, Thirty-day stroke, death, and combined stroke-death rates in patients with symptomatic disease. Numbers
in parentheses represent number of CEA performed. P not significant for all comparisons.
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nature of the carotid lesion. It has often been assumed that
patients who survive CEA can be expected to derive similar
long-term benefits as those observed in the randomized
trials, but such an assumption is clearly flawed when applied
to cohorts excluded from those trials. In our series, 3-year
survival for patients with more than two risk factors was
59% 5%. By way of comparison, mortality rates observed
in the surgical arms of ACAS and NASCET were 3.7% per
year and 4.6% at 2 years, respectively. Inasmuch as improve-
ment in outcome for patients randomized to CEA in the
ACAS trial did not reach significance until 3 years after
surgery, we interpret this as a further note of caution in
management of asymptomatic carotid artery disease in pa-
tients with multiple comorbid conditions.
The influence of contralateral occlusion on CEA out-
come remains controversial. Several other groups have
found contralateral occlusion to be associated with adverse
outcome.4,13,14 Secondary analysis of the ACAS data by
Baker et al6 found that CEA in patients with asymptomatic
contralateral carotid occlusion provided no long-term ben-
efit in preventing stroke and death, despite an acceptable
perioperative event rate of 2.3%. A more recent study15 of a
much larger cohort (n 338) of patients with contralateral
occlusion found no effect on perioperative events, but
long-term results were not reported. In our study this was
the only variable tested that demonstrated an association
with increased perioperative stroke (5.3%). Perhaps a more
salient finding is the markedly reduced long-term survival
(38% 11% at 5 years) associated with contralateral carotid
occlusion.
Our results parallel those of others3 in demonstrating
the safety of CEA in octogenarians. A recent analysis of
NASCET data demonstrated that patients 75 years and
older with 50% to 99% symptomatic carotid stenosis exhib-
ited greater benefit from CEA than younger patients did.16
It is also worth noting that Roubin et al17 reported that age
older than 80 years is associated with increased risk for
periprocedural stroke and death (16%) after carotid stent-
ing. Until randomized trials can be conducted, CEA ap-
pears to be a safer and more efficacious alternative in the
elderly.
Several reports have attempted to define risk factors for
early adverse outcomes after CEA. Ferguson et al4 reported
outcome for the entire surgical arm (n 1415 patients) of
NASCET. Using regression modeling these authors iden-
tified hemispheric TIA, contralateral occlusion, left-sided
Table III. Univariate and Poisson regression analysis of individual risk factors for combined stroke-death end point in all
patients undergoing isolated CEA
Patient characteristics
P
Odds ratio 95% confidence interval
Univariate
analysis Poisson regression
CABG in 6 mo 1.000
CHF .069 .058 5.78 0.90  41.67
COPD .426
Creatinine 2.0
mg/dL
.115
Contralateral
occlusion
.011 .011 4.33 1.23  12.26
Repeat CEA .503
Age 80 y .495
Recent hemispheric
stroke or TIA
.816
CEA, Carotid endarterectomy; CABG, coronary artery bypass grafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; RF, risk
factor; TIA, transient ischemic attack.
Table IV. Survival rates after CEA
Patient group
Overall Symptomatic Asymptomatic
2 year 5 year 2 year 5 year 2 year 5 year
Low risk (%) 95  1 75  3 97  2 79  4 93  1 72  3
1 High risk factor (%) 91  2 66  3 92  2 69  3 89  3 49  7
2 High risk factors (%) 78  4 39  6* 80  4 41  6† 74  11 47  17†
With contralateral occlusion (%) 82  5 38  11* 84  9 30  14‡ 81  7 33  18‡
Without contralateral occlusion (%) 92  1 67  2 91  1 66  3 92  1 64  3
CEA, Carotid endarterectomy.
*P.001 when comparing 5-year survival between low risk and 1 RF vs2 RF; P.05 when comparing 2-year and 5-year survival between all patients with
and without contralateral occlusion.
†P .001 when comparing 5-year survival between patients with low risk vs 2 RF.
‡P  when comparing 5-year survival of patients with symptomatic and asymptomatic disease with and without contralateral occlusion.
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procedure, ischemic lesion identified on CT scans, and
plaque ulceration as factors associated with increased surgi-
cal risk. Lepore et al3 examined their surgical outcomes in
patients ineligible for the randomized CEA trials. Their
results are markedly similar to ours in that 46% of their
overall series were “trial ineligible” and adverse outcomes
were not significantly increased in that population. Ouriel
et al5 reviewed their results in 3061 patients at The Cleve-
land Clinic, comparing a defined high-risk group that in-
cluded patients with recent coronary interventions, CHF,
COPD, or chronic renal insufficiency. They reported a
higher overall event rate in this high-risk group, but 67% of
those patients underwent combined CEA-CABG proce-
dures (with 15.5% adverse outcome rate), severely limiting
the applicability of their results to isolated CEA. Gasparis et
al7 reviewed outcomes in a somewhat smaller series (n 
788) and found no significant influence of a similar set of
risk factors on perioperative events. Multivariate analysis of
individual risk factors and assessment of long-term survival
were not reported in the last three cited studies.
Fig 2. Long-term survival after isolated carotid endarterectomy, according to risk factor cohorts. RF, Risk factor. *All
standard error for cumulative survival less than 5.9% except where noted. **Standard error 8.4%, 9.6%, and 10.7%,
respectively.
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In this retrospective review, combined CEA-CABG
resulted in a higher stroke rate than did isolated CEA;
however, this finding must be interpreted with caution,
because of lack of a defined protocol for selecting the
combined procedure and the disparate nature of the
groups. We found that only 3 of 12 postCEA-CABG
strokes were ipsilateral to CEA, reflecting the complexity of
cerebral infarction in this setting. Others have documented
similar findings of increased perioperative stroke risk for
CEA-CABG, but definitive conclusions in this cohort have
yet to be reached. On the basis of our findings and those of
Ouriel et al,5 it may be reasonable to consider CEA-CABG
candidates among the group in whom carotid stenting
should be explored.
This study has several important limitations that are
similar to those attributable to other recent reports. Be-
cause of its retrospective nature, completeness of adverse
event reporting may be questioned, and any comparisons
with prospective randomized trials must be interpreted in
that light. Most notably, the relatively small number of
adverse events (32, 2.3%), combined with low prevalence of
some risk factors, limits the statistical power for analyzing
influence of individual factors. Thus negative findings must
be interpreted with some caution. We selected the variables
on the basis of trial criteria, published reports, and data
availability in our registry; however, other potentially im-
portant risk factors, eg, uncorrected severe coronary artery
disease, were not analyzed. Our database did not permit
identification of patients with severe coronary artery dis-
ease, which implies that they are either included among the
group with no risk factors who underwent only CEA or,
more likely, underwent CABG-CEA. While we were able to
obtain long-term survival data from the Social Security
Index database, we do not have reliable information on late
stroke prevention.
CONCLUSION
CEA, when performed by experienced practitioners in
substantial volume, carries a low risk for perioperative
stroke or death in most patients. Although we observed a
trend toward higher perioperative mortality in patients with
multiple comorbid conditions, the adverse event rates
noted in patients with these risk factors still fall within the
range of those reported in randomized trials and within
those proposed by the American Heart Association12 as
practice guidelines, ie, combined stroke-death rate of 3% in
patients with asymptomatic disease and 6% in those with
symptomatic disease. A cautious exception is noted in the
small subgroup of patients with asymptomatic disease with
multiple risk factors, who demonstrated an elevated mor-
tality rate in this series. We identified only contralateral
carotid occlusion as a significant independent risk factor
associated with a modest increase in perioperative stroke
and death (6.7%). However, this series demonstrates that
patients with multiple risk factors for CEA have reduced
long-term survival, and thus caution may be warranted,
particularly in the context of asymptomatic disease, regard-
less of the form of carotid intervention being considered.
Alternative approaches should be examined for patients
who are considered candidates for combined CEA-CABG.
Further studies are needed to identify subgroups of patients
in whom percutaneous methods might truly be expected to
offer a safety advantage.
We thank Ms Julie Lombara for assistance in data
preparation.
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